HK1213182A1 - Pharmaceutical composition for external application - Google Patents
Pharmaceutical composition for external applicationInfo
- Publication number
- HK1213182A1 HK1213182A1 HK16101140.9A HK16101140A HK1213182A1 HK 1213182 A1 HK1213182 A1 HK 1213182A1 HK 16101140 A HK16101140 A HK 16101140A HK 1213182 A1 HK1213182 A1 HK 1213182A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- external application
- external
- application
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013072157 | 2013-03-29 | ||
PCT/JP2014/058716 WO2014157436A1 (en) | 2013-03-29 | 2014-03-27 | Pharmaceutical composition for external application |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1213182A1 true HK1213182A1 (en) | 2016-06-30 |
Family
ID=51624398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16101140.9A HK1213182A1 (en) | 2013-03-29 | 2016-02-01 | Pharmaceutical composition for external application |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP6738120B2 (en) |
CN (1) | CN105246471A (en) |
HK (1) | HK1213182A1 (en) |
TW (1) | TWI671069B (en) |
WO (1) | WO2014157436A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6599083B2 (en) * | 2014-03-30 | 2019-10-30 | 小林製薬株式会社 | Pharmaceutical composition for external use |
JP6580306B2 (en) * | 2014-03-30 | 2019-09-25 | 小林製薬株式会社 | Pharmaceutical composition for external use |
JP6580305B2 (en) * | 2014-03-30 | 2019-09-25 | 小林製薬株式会社 | Pharmaceutical composition for external use |
JP6959594B2 (en) * | 2014-11-12 | 2021-11-02 | 三笠製薬株式会社 | Anti-inflammatory topical agent |
JP6535853B2 (en) * | 2014-11-12 | 2019-07-03 | 三笠製薬株式会社 | Anti-inflammatory external preparation |
US11090265B2 (en) | 2015-01-30 | 2021-08-17 | Medrx Co., Ltd. | Aqueous preparation for external use |
JP6817733B2 (en) * | 2016-07-07 | 2021-01-20 | 小林製薬株式会社 | Preparation for internal bleeding treatment |
CN110114061A (en) * | 2016-12-28 | 2019-08-09 | 小林制药株式会社 | Topical composition |
WO2018230687A1 (en) * | 2017-06-16 | 2018-12-20 | 株式会社 メドレックス | Anti-inflammatory and analgesic drug for external use |
JP2022096997A (en) * | 2020-12-18 | 2022-06-30 | 小林製薬株式会社 | Pharmaceutical composition for external use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0780772B2 (en) * | 1989-03-07 | 1995-08-30 | 積水化学工業株式会社 | Transdermal formulation |
JP3280711B2 (en) * | 1992-08-26 | 2002-05-13 | 積水化学工業株式会社 | Transdermal formulation |
JPH07267862A (en) * | 1994-03-29 | 1995-10-17 | Sekisui Chem Co Ltd | Transdermal plaster |
JPH07285887A (en) * | 1994-04-15 | 1995-10-31 | Oishi Kouseidou:Kk | Base for plaster |
JP2006036687A (en) * | 2004-07-27 | 2006-02-09 | Nippon Zoki Pharmaceut Co Ltd | Tramadol-containing medicinal composition for external use |
JP5233149B2 (en) * | 2007-03-31 | 2013-07-10 | 大正製薬株式会社 | Adapalene-containing external preparation composition |
CH699814B1 (en) * | 2007-05-14 | 2010-05-14 | Mepha Ag | Diclofenac for topical application as a spray. |
WO2009047785A2 (en) * | 2007-06-08 | 2009-04-16 | Patel Ketan R | A non-aqueous topical solution of diclofenac and process for preparing the same |
US20110294763A1 (en) * | 2009-01-30 | 2011-12-01 | Dordunoo Stephen K | Transdermal delivery of dicolfenac, carbamazepine and benzydamine |
JP2012193176A (en) * | 2011-03-03 | 2012-10-11 | Nippon Zoki Pharmaceut Co Ltd | Milnacipran-containing pharmaceutical composition for percutaneous absorption |
JP2014101338A (en) * | 2012-11-22 | 2014-06-05 | Japan Medic Kk | Anti-inflammation and analgesic topical medicament |
-
2014
- 2014-03-25 JP JP2014061931A patent/JP6738120B2/en active Active
- 2014-03-27 CN CN201480030469.8A patent/CN105246471A/en active Pending
- 2014-03-27 WO PCT/JP2014/058716 patent/WO2014157436A1/en active Application Filing
- 2014-03-28 TW TW103111769A patent/TWI671069B/en active
-
2016
- 2016-02-01 HK HK16101140.9A patent/HK1213182A1/en unknown
-
2018
- 2018-12-11 JP JP2018231489A patent/JP6794420B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019034978A (en) | 2019-03-07 |
TWI671069B (en) | 2019-09-11 |
JP6738120B2 (en) | 2020-08-12 |
JP2014208623A (en) | 2014-11-06 |
WO2014157436A1 (en) | 2014-10-02 |
JP6794420B2 (en) | 2020-12-02 |
CN105246471A (en) | 2016-01-13 |
TW201444553A (en) | 2014-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288961A (en) | Pharmaceutical compositions | |
HUE046964T2 (en) | Combined pharmaceutical composition | |
PL2943181T3 (en) | Pharmaceutical compositions | |
GB201322602D0 (en) | Pharmaceutical compounds | |
GB201306610D0 (en) | Pharmaceutical compounds | |
PL3043778T3 (en) | Pharmaceutical compositions containing refametinib | |
ZA201408333B (en) | Pharmaceutical compositions | |
HK1213182A1 (en) | Pharmaceutical composition for external application | |
EP2990038A4 (en) | Solid pharmaceutical composition | |
IL244380A0 (en) | Pharmaceutical compounds | |
SG11201601477VA (en) | Pharmaceutical composition | |
GB201312386D0 (en) | Pharmaceutical compounds | |
HUP1300496A2 (en) | Stable pharmaceutical composition | |
HRP20171888T1 (en) | Pharmaceutical compositions | |
HK1220143A1 (en) | Pharmaceutical composition | |
EP2992890A4 (en) | Pharmaceutical composition | |
GB201304699D0 (en) | Pharmaceutical compositions | |
GB201304625D0 (en) | New pharmaceutical composition | |
GB201321497D0 (en) | Pharmaceutical compositions | |
GB201312851D0 (en) | Pharmaceutical compositions | |
AU2013903813A0 (en) | Pharmaceutical composition | |
GB201317166D0 (en) | Pharmaceutical compounds | |
GB201316780D0 (en) | Pharmaceutical compounds | |
GB201316791D0 (en) | Pharmaceutical Compounds | |
GB201315733D0 (en) | Pharmaceutical compounds |